Selected research
Industry Research
TACE Embolic Microspheres Industry Research Report 2026
Market perspective
The global TACE Embolic Microspheres market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for TACE Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for TACE Embolic Microspheres is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for TACE Embolic Microspheres is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of TACE Embolic Microspheres include ABK Biomedical, Boston Scientific, Merit Medical, Mermaid Medical, Sirtex Medical, Terumo, Varian, Cardiolink Science and Suzhou Hengrui Medical Equipment, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global TACE Embolic Microspheres market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
TACE Embolic Microspheres Market by Company
ABK Biomedical
Boston Scientific
Merit Medical
Mermaid Medical
Sirtex Medical
Terumo
Varian
Cardiolink Science
Suzhou Hengrui Medical Equipment
TACE Embolic Microspheres Segment by Type
Common Embolic Microspheres
Drug-Loadable Embolic Microspheres
TACE Embolic Microspheres Segment by Application
Colorectal Cancer Liver Metastasis
Primary Liver Cancer
Others
TACE Embolic Microspheres Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TACE Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of TACE Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TACE Embolic Microspheres.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of TACE Embolic Microspheres manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of TACE Embolic Microspheres by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of TACE Embolic Microspheres in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Common Embolic Microspheres
- Drug-Loadable Embolic Microspheres
Applications
- Colorectal Cancer Liver Metastasis
- Primary Liver Cancer
- Others
Companies covered
- ABK Biomedical
- Boston Scientific
- Merit Medical
- Mermaid Medical
- Sirtex Medical
- Terumo
- Varian
- Cardiolink Science
- Suzhou Hengrui Medical Equipment
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global TACE Embolic Microspheres Market Size (2021-2032)
- 2.2.2 Global TACE Embolic Microspheres Sales (2021-2032)
- 2.2.3 Global TACE Embolic Microspheres Market Average Price (2021-2032)
- 2.3 TACE Embolic Microspheres by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Common Embolic Microspheres
- 2.3.3 Drug-Loadable Embolic Microspheres
- 2.4 TACE Embolic Microspheres by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Colorectal Cancer Liver Metastasis
- 2.4.3 Primary Liver Cancer
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global TACE Embolic Microspheres Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global TACE Embolic Microspheres Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global TACE Embolic Microspheres Revenue of Manufacturers (2021-2026)
- 3.4 Global TACE Embolic Microspheres Average Price by Manufacturers (2021-2026)
- 3.5 Global TACE Embolic Microspheres Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of TACE Embolic Microspheres, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of TACE Embolic Microspheres, Product Type & Application
- 3.8 Global Manufacturers of TACE Embolic Microspheres, Established Date
- 3.9 Global TACE Embolic Microspheres Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ABK Biomedical
- 4.1.1 ABK Biomedical Company Information
- 4.1.2 ABK Biomedical Business Overview
- 4.1.3 ABK Biomedical TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 ABK Biomedical TACE Embolic Microspheres Product Portfolio
- 4.1.5 ABK Biomedical Recent Developments
- 4.2 Boston Scientific
- 4.2.1 Boston Scientific Company Information
- 4.2.2 Boston Scientific Business Overview
- 4.2.3 Boston Scientific TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boston Scientific TACE Embolic Microspheres Product Portfolio
- 4.2.5 Boston Scientific Recent Developments
- 4.3 Merit Medical
- 4.3.1 Merit Medical Company Information
- 4.3.2 Merit Medical Business Overview
- 4.3.3 Merit Medical TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merit Medical TACE Embolic Microspheres Product Portfolio
- 4.3.5 Merit Medical Recent Developments
- 4.4 Mermaid Medical
- 4.4.1 Mermaid Medical Company Information
- 4.4.2 Mermaid Medical Business Overview
- 4.4.3 Mermaid Medical TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mermaid Medical TACE Embolic Microspheres Product Portfolio
- 4.4.5 Mermaid Medical Recent Developments
- 4.5 Sirtex Medical
- 4.5.1 Sirtex Medical Company Information
- 4.5.2 Sirtex Medical Business Overview
- 4.5.3 Sirtex Medical TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sirtex Medical TACE Embolic Microspheres Product Portfolio
- 4.5.5 Sirtex Medical Recent Developments
- 4.6 Terumo
- 4.6.1 Terumo Company Information
- 4.6.2 Terumo Business Overview
- 4.6.3 Terumo TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Terumo TACE Embolic Microspheres Product Portfolio
- 4.6.5 Terumo Recent Developments
- 4.7 Varian
- 4.7.1 Varian Company Information
- 4.7.2 Varian Business Overview
- 4.7.3 Varian TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Varian TACE Embolic Microspheres Product Portfolio
- 4.7.5 Varian Recent Developments
- 4.8 Cardiolink Science
- 4.8.1 Cardiolink Science Company Information
- 4.8.2 Cardiolink Science Business Overview
- 4.8.3 Cardiolink Science TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Cardiolink Science TACE Embolic Microspheres Product Portfolio
- 4.8.5 Cardiolink Science Recent Developments
- 4.9 Suzhou Hengrui Medical Equipment
- 4.9.1 Suzhou Hengrui Medical Equipment Company Information
- 4.9.2 Suzhou Hengrui Medical Equipment Business Overview
- 4.9.3 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Suzhou Hengrui Medical Equipment TACE Embolic Microspheres Product Portfolio
- 4.9.5 Suzhou Hengrui Medical Equipment Recent Developments
5 Global TACE Embolic Microspheres Market Scenario by Region
- 5.1 Global TACE Embolic Microspheres Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global TACE Embolic Microspheres Sales by Region: 2021-2032
- 5.2.1 Global TACE Embolic Microspheres Sales by Region: 2021-2026
- 5.2.2 Global TACE Embolic Microspheres Sales by Region: 2027-2032
- 5.3 Global TACE Embolic Microspheres Revenue by Region: 2021-2032
- 5.3.1 Global TACE Embolic Microspheres Revenue by Region: 2021-2026
- 5.3.2 Global TACE Embolic Microspheres Revenue by Region: 2027-2032
- 5.4 North America TACE Embolic Microspheres Market Facts & Figures by Country
- 5.4.1 North America TACE Embolic Microspheres Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America TACE Embolic Microspheres Sales by Country (2021-2032)
- 5.4.3 North America TACE Embolic Microspheres Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe TACE Embolic Microspheres Market Facts & Figures by Country
- 5.5.1 Europe TACE Embolic Microspheres Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe TACE Embolic Microspheres Sales by Country (2021-2032)
- 5.5.3 Europe TACE Embolic Microspheres Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific TACE Embolic Microspheres Market Facts & Figures by Country
- 5.6.1 Asia Pacific TACE Embolic Microspheres Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific TACE Embolic Microspheres Sales by Country (2021-2032)
- 5.6.3 Asia Pacific TACE Embolic Microspheres Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America TACE Embolic Microspheres Market Facts & Figures by Country
- 5.7.1 South America TACE Embolic Microspheres Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America TACE Embolic Microspheres Sales by Country (2021-2032)
- 5.7.3 South America TACE Embolic Microspheres Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa TACE Embolic Microspheres Market Facts & Figures by Country
- 5.8.1 Middle East and Africa TACE Embolic Microspheres Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa TACE Embolic Microspheres Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa TACE Embolic Microspheres Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global TACE Embolic Microspheres Sales by Type (2021-2032)
- 6.1.1 Global TACE Embolic Microspheres Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global TACE Embolic Microspheres Sales Market Share by Type (2021-2032)
- 6.2 Global TACE Embolic Microspheres Revenue by Type (2021-2032)
- 6.2.1 Global TACE Embolic Microspheres Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global TACE Embolic Microspheres Revenue Market Share by Type (2021-2032)
- 6.3 Global TACE Embolic Microspheres Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global TACE Embolic Microspheres Sales by Application (2021-2032)
- 7.1.1 Global TACE Embolic Microspheres Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global TACE Embolic Microspheres Sales Market Share by Application (2021-2032)
- 7.2 Global TACE Embolic Microspheres Revenue by Application (2021-2032)
- 7.2.1 Global TACE Embolic Microspheres Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global TACE Embolic Microspheres Revenue Market Share by Application (2021-2032)
- 7.3 Global TACE Embolic Microspheres Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 TACE Embolic Microspheres Value Chain Analysis
- 8.1.1 TACE Embolic Microspheres Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 TACE Embolic Microspheres Production Mode & Process
- 8.2 TACE Embolic Microspheres Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 TACE Embolic Microspheres Distributors
- 8.2.3 TACE Embolic Microspheres Customers
9 Global TACE Embolic Microspheres Analyzing Market Dynamics
- 9.1 TACE Embolic Microspheres Industry Trends
- 9.2 TACE Embolic Microspheres Industry Drivers
- 9.3 TACE Embolic Microspheres Industry Opportunities and Challenges
- 9.4 TACE Embolic Microspheres Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst